Your browser doesn't support javascript.
Turning point: A new global COVID-19 wave or a signal of the beginning of the end of the global COVID-19 pandemic?
Ding, Kaixi; Jiang, Wei; Xiong, Chunping; Lei, Ming.
  • Ding K; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Jiang W; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Xiong C; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Lei M; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Immun Inflamm Dis ; 10(4): e606, 2022 04.
Article in English | MEDLINE | ID: covidwho-1763240
ABSTRACT
A new variant named Omicron (B.1.1.529), first identified in South Africa, has become of considerable interest to the World Health Organization. This variant differs from the other known major variants, as it carries a large number of unusual mutations, particularly in the spinous process protein and receptor binding domains. Some specific mutation sites make it vaccine resistant, highly infectious, and highly pathogenic. The world fears that the Omicron variant could be even more harmful than the previous major variant, given that it has emerged amid fierce competition to trigger a new global pandemic peak as infections in South Africa rise. However, some epidemiological evidence has emerged that the Omicron variant may produce milder patient symptoms. We speculate if the virulence of the Omicron variant will diminish as transmissibility increases, thereby signaling the beginning of the end for the global COVID-19 pandemic. Based on this view, we make recommendations for COVID-19 mitigation in the present and future. However, it will take a few weeks to determine the true threat posed by the Omicron variant and we need to be fully prepared for future outbreaks, regardless of their severity.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza, Human / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines / Variants Limits: Humans Language: English Journal: Immun Inflamm Dis Year: 2022 Document Type: Article Affiliation country: Iid3.606

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza, Human / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines / Variants Limits: Humans Language: English Journal: Immun Inflamm Dis Year: 2022 Document Type: Article Affiliation country: Iid3.606